Regional Biocontainment Laboratory (RBL) Upgrade for Colorado State University (CSU)
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3G20AI167348-01S1
Grant search
Key facts
Disease
Disease XStart & end year
20212025Known Financial Commitments (USD)
$3,193,195Funder
National Institutes of Health (NIH)Principal Investigator
PROFESSOR Karen DobosResearch Location
United States of AmericaLead Research Institution
COLORADO STATE UNIVERSITYResearch Priority Alignment
N/A
Research Category
13
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Project Summary / Abstract The funding and implementation of this supplement is essential to maintain uninterrupted research and scholarly activity in CSU’s Rocky Mountain Regional Biocontainment Laboratory (RMRBL). Research activities that occur at the RMRBL directly address the RBLs’ missions to respond to and prevent global infectious disease threats. Our efforts are the evolution of over 4 decades of research conducted at CSU predominately sponsored by NIAID, and includes interdisciplinary research teams studying Flaviviridae, Togaviridae, Bunyavirales, Coronaviridae viral pathogens along with robust programs in mycobacteria, anti microbial resistance, and vector borne bacterial pathogens. The RBL is integral for this infectious disease research, training and other scholarly activities. The RMRBL recently benefitted from a G20 award specific to much needed modernization and infrastructure upgrades. However, these investments continue to be needed due to the complexity and high use of this facility. Here, we add to the Specific Aims of our parent G20 award to continue to make critical investments to improve our biosafety, animal modeling, and imaging research needs.